Loading...
XTSELABS
Market cap21mUSD
Jan 08, Last price  
0.08CAD
1D
15.38%
1Q
0.00%
IPO
-97.63%
Name

Medipharm Labs Corp

Chart & Performance

D1W1MN
XTSE:LABS chart
P/E
P/S
0.93
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
38.00%
Rev. gr., 5y
26.52%
Revenues
33m
+49.49%
0010,198,000129,252,00036,012,00021,711,00022,117,00033,061,999
Net income
-13m
L-56.37%
-133,936-990,000-8,411,0001,131,000-67,110,000-54,801,000-29,983,000-13,083,000
CFO
-12m
L-23.21%
-54,692166,000-11,113,000-25,265,000-37,773,000-13,213,000-16,069,000-12,339,000
Earnings
Mar 27, 2025

Profile

MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada, Australia, Germany, and internationally. It formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. The company also provides GMP flower sourcing, packaging, and distribution services. MediPharm Labs Corp. was founded in 2015 and is headquartered in Barrie, Canada.
IPO date
Feb 09, 2018
Employees
130
Domiciled in
CA
Incorporated in
CA

Valuation

Title
CAD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑092016‑12
Income
Revenues
33,062
49.49%
22,117
1.87%
Cost of revenue
52,212
49,790
Unusual Expense (Income)
NOPBT
(19,150)
(27,673)
NOPBT Margin
Operating Taxes
(276)
(6)
Tax Rate
NOPAT
(18,874)
(27,667)
Net income
(13,083)
-56.37%
(29,983)
-45.29%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,226
598
Long-term debt
259
143
Deferred revenue
Other long-term liabilities
Net debt
(15,496)
(23,404)
Cash flow
Cash from operating activities
(12,339)
(16,069)
CAPEX
(471)
(863)
Cash from investing activities
6,872
5,158
Cash from financing activities
(368)
796
FCF
(21,708)
(11,553)
Balance
Cash
17,981
24,145
Long term investments
Excess cash
16,328
23,039
Stockholders' equity
53,005
56,005
Invested Capital
38,972
33,598
ROIC
ROCE
EV
Common stock shares outstanding
363,324
276,861
Price
0.07
-7.14%
0.07
-62.16%
Market cap
23,616
21.86%
19,380
-58.08%
EV
8,120
(4,024)
EBITDA
(16,634)
(24,801)
EV/EBITDA
0.16
Interest
365
31
Interest/NOPBT